Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Sheng Wang

Showing results (401-410 of 429) with videos related to

Pageof 43
Sort By:
Cell Metabolism|May 3, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in SteatohepatitisXinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Cell Metabolism|July 2, 2020
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 PathogenesisJin-Wen Song, Sin Man Lam, Xing Fan, et al.
Hepatology International|December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trialFanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
World Journal of Gastroenterology|March 31, 2018
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infectionLai Wei, Fu-Sheng Wang, Ming-Xiang Zhang, et al.
Stem Cell Research & Therapy|February 26, 2025
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trialMeng-Qi Yuan, Le Song, Ze-Rui Wang, et al.
Nature Metabolism|June 23, 2021
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Ebiomedicine|May 7, 2023
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialTian-Tian Li, Bo Zhang, Hui Fang, et al.
Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
Ebiomedicine|June 29, 2026
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infectionYou-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, et al.
Pageof 43

Showing results (401-410 of 429) with videos related to

Sort By:
Pageof 43
Cell Metabolism|May 3, 2018
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in SteatohepatitisXinshou Ouyang, Sheng-Na Han, Ji-Yuan Zhang, et al.
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Cell Metabolism|July 2, 2020
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 PathogenesisJin-Wen Song, Sin Man Lam, Xing Fan, et al.
Hepatology International|December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trialFanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
World Journal of Gastroenterology|March 31, 2018
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infectionLai Wei, Fu-Sheng Wang, Ming-Xiang Zhang, et al.
Stem Cell Research & Therapy|February 26, 2025
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trialMeng-Qi Yuan, Le Song, Ze-Rui Wang, et al.
Nature Metabolism|June 23, 2021
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19Sin Man Lam, Chao Zhang, Zehua Wang, et al.
Ebiomedicine|May 7, 2023
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialTian-Tian Li, Bo Zhang, Hui Fang, et al.
Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
Ebiomedicine|June 29, 2026
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infectionYou-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, et al.
Pageof 43